A New Molecular Predictor of Distant Recurrence in ER-Positive, HER2-Negative Breast Cancer Adds Independent Information to Conventional Clinical Risk Factors

  • Martin Filipits
  • , Margaretha Rudas
  • , Raimund Jakesz
  • , Peter Dubsky
  • , Florian Fitzal
  • , Christian F Singer
  • , Otto Dietze (Co-author)
  • , Richard Greil (Co-author)
  • , Andrea Jelen
  • , Paul Sevelda
  • , Christa Freibauer
  • , Volkmar Müller
  • , Fritz Jänicke
  • , Marcus Schmidt
  • , Heinz Kölbl
  • , Achim Rody
  • , Manfred Kaufmann
  • , Werner Schroth
  • , Hiltrud Brauch
  • , Matthias Schwab
  • Peter Fritz, Karsten E Weber, Inke S Feder, Guido Hennig, Ralf Kronenwett, Mathias Gehrmann, Michael Gnant

Research output: Contribution to journalOriginal Articlepeer-review

531 Citations (Web of Science)
Original languageEnglish
Pages (from-to)6012-6020
JournalCLINICAL CANCER RESEARCH
Volume17
Issue number18
DOIs
Publication statusPublished - 2011

Keywords

  • POSTMENOPAUSAL WOMEN
  • ADJUVANT TAMOXIFEN
  • EXPRESSION
  • TRIAL
  • SIGNATURE
  • SURVIVAL

Cite this